BIOGEN publishes study results for high-dose nusinersen in Nature Medicine
Go back to BIOGEN publishes study results for high-dose nusinersen in Nature Medicine| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 218.50 -3 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.50 | 52 Week High | $333.65 | |||
| Open | $221.17 | 52 Week Low | $223.02 | |||
| Day High | $222.00 | P/E | 27.98 | |||
| Day Low | $216.78 | EPS | $7.81 | |||
| Volume | 517,485 | |||||
| (NASDAQ: IONS) | Delayed: 61.05 -1.38 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.43 | 52 Week High | $62.68 | |||
| Open | $60.62 | 52 Week Low | $19.59 | |||
| Day High | $61.69 | P/E | N/A | |||
| Day Low | $60.35 | EPS | $0.00 | |||
| Volume | 1,850,853 | |||||
